Metal-Containing Molecules and Nanomaterials: From Diagnosis to Therapy: Metal Ions in Life Sciences Series
Editat de Ana de Bettencourt-Diasen Limba Engleză Hardback – 25 iul 2024
Features:
- The field of metallodrugs has been flourishing and this area of research can be used to diagnose specific biologically relevant molecules or unravel cellular metabolism.
- The authors are preeminent bioinorganic and medicinal inorganic chemists and review the most current research in this field.
- The book discusses the properties and therapeutic applications of metals and metal-containing molecules including the use of electrochemical or optical signal for diagnosis of biologically relevant molecules.
- It endorses and stimulates research in the vibrant field of biological inorganic chemistry.
- It reviews the most current research supporting the relevance of metal-containing molecules and nanomaterials for diagnosis and therapy.
Preț: 866.90 lei
Preț vechi: 952.64 lei
-9% Nou
Puncte Express: 1300
Preț estimativ în valută:
165.96€ • 170.68$ • 137.68£
165.96€ • 170.68$ • 137.68£
Carte disponibilă
Livrare economică 29 ianuarie-12 februarie
Livrare express 14-18 ianuarie pentru 32.61 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781032422145
ISBN-10: 1032422149
Pagini: 188
Ilustrații: 134
Dimensiuni: 152 x 229 x 16 mm
Greutate: 0.51 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Metal Ions in Life Sciences Series
Locul publicării:Boca Raton, United States
ISBN-10: 1032422149
Pagini: 188
Ilustrații: 134
Dimensiuni: 152 x 229 x 16 mm
Greutate: 0.51 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Metal Ions in Life Sciences Series
Locul publicării:Boca Raton, United States
Public țintă
Postgraduate, Professional, and Undergraduate AdvancedNotă biografică
Ana de Bettencourt-Dias received her ‘licenciatura’ (MS equivalent) in Technological Chemistry from the University of Lisbon in 1993, and her ‘Dr. rer. nat.’ (PhD equivalent) in Inorganic Chemistry from the University of Cologne in 1997 with Prof. Thomas Kruck. In her graduate work, she isolated new titanium complexes as single source precursors for the chemical vapor deposition of TiN thin layers. She joined the group of Prof. Alan Balch at UC Davis in 1998 as a Gulbenkian postdoctoral fellow, where she studied the electrochemistry and structure of fullerenes and endohedral fullerenes.
Cuprins
Chapter 1 Electrochemical Sensors with Inorganic Redox Mediators
Mario A. Alpuche-Aviles
Chapter 2 Recent Advances of Medicinal Properties of Vanadium Compounds: Cancer and Other Diseases
Kateryna Kostenkova, Kameron Klugh, and Debbie C. Crans
Chapter 3 Ruthenium-Phthalocyanine Compounds as Prototypes for Photodynamic Therapy
Amanda Blanque Becceneri, Matheus Torelli Martin, Francisco Rinaldi Neto, Peter C. Ford, and Roberto Santana da Silva
Chapter 4 Metal Complexes as Probes and Inhibitors of Metabolic Enzymes
Madeline Denison, Claudia Turro, and Jeremy J. Kodanko
Chapter 5 Heme-Based Therapeutics
Elmira Alipour, Mark T. Gladwin, and Daniel B. Kim-Shapiro
Chapter 6 Metal-Containing and Metal-Associated Dietary Nutrients
Rebeca L. Fernandez, Vanessa J. Lee, and Marie C. Heffern
Chapter 7 Why is Gadolinium Still Preferred in Contrast Agents for MRI?
Mark Woods and Mauro Botta
Mario A. Alpuche-Aviles
Chapter 2 Recent Advances of Medicinal Properties of Vanadium Compounds: Cancer and Other Diseases
Kateryna Kostenkova, Kameron Klugh, and Debbie C. Crans
Chapter 3 Ruthenium-Phthalocyanine Compounds as Prototypes for Photodynamic Therapy
Amanda Blanque Becceneri, Matheus Torelli Martin, Francisco Rinaldi Neto, Peter C. Ford, and Roberto Santana da Silva
Chapter 4 Metal Complexes as Probes and Inhibitors of Metabolic Enzymes
Madeline Denison, Claudia Turro, and Jeremy J. Kodanko
Chapter 5 Heme-Based Therapeutics
Elmira Alipour, Mark T. Gladwin, and Daniel B. Kim-Shapiro
Chapter 6 Metal-Containing and Metal-Associated Dietary Nutrients
Rebeca L. Fernandez, Vanessa J. Lee, and Marie C. Heffern
Chapter 7 Why is Gadolinium Still Preferred in Contrast Agents for MRI?
Mark Woods and Mauro Botta
Descriere
Since the discovery and successful deployment of salvarsan to treat syphilis, as well as cisplatin as a cancer drug, the field of metallodrugs has been flourishing.